Meadow Creek Investment Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$254K Hold
1,808
0.01% 953
2019
Q2
$331K Buy
1,808
+80
+5% +$14.6K 0.01% 866
2019
Q1
$275K Buy
1,728
+224
+15% +$35.6K 0.01% 906
2018
Q4
$144K Sell
1,504
-96
-6% -$9.19K ﹤0.01% 1063
2018
Q3
$226K Buy
1,600
+1,280
+400% +$181K ﹤0.01% 1036
2018
Q2
$50K Buy
320
+304
+1,900% +$47.5K ﹤0.01% 1257
2018
Q1
$3K Buy
+16
New +$3K ﹤0.01% 1324